Edap Tms (NASDAQ: EDAP) and PhotoMedex (NASDAQ:PHMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitabiliy, earnings and valuation.

Institutional & Insider Ownership

8.0% of Edap Tms shares are held by institutional investors. Comparatively, 5.2% of PhotoMedex shares are held by institutional investors. 22.4% of PhotoMedex shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Edap Tms and PhotoMedexs gross revenue, earnings per share and valuation.

Edap Tms has higher revenue and earnings than PhotoMedex.

Risk & Volatility

Edap Tms has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, PhotoMedex has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Edap Tms and PhotoMedex, as provided by MarketBeat.

Edap Tms presently has a consensus price target of $7.00, suggesting a potential upside of 137.29%. Given Edap Tms higher possible upside, equities analysts plainly believe Edap Tms is more favorable than PhotoMedex.

Profitability

This table compares Edap Tms and PhotoMedexs net margins, return on equity and return on assets.

Summary

Edap Tms beats PhotoMedex on 10 of the 11 factors compared between the two stocks.

About Edap Tms

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.

About PhotoMedex

PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Companys Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

See the rest here:

Edap Tms (NASDAQ:EDAP) and PhotoMedex (PHMD) Head to ... - BNB Daily (blog)